Welcome to our dedicated page for UTime SEC filings (Ticker: WTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UTime's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UTime's regulatory disclosures and financial reporting.
UTime Limited reported the launch of a smartwatch with integrated blood pressure monitoring, expanding its product portfolio in the health technology sector. The update was disclosed via a Form 6-K and accompanied by a press release dated October 28, 2025.
This addition signals a push into health-focused wearables, aligning the company with growing demand for biometric tracking devices. The filing did not include financial details or performance metrics for the new product.
UTime Limited filed an amended Form 6-K to correct the record date tied to its upcoming Extraordinary General Meeting of Shareholders. The amendment updates Exhibit 99.1.
The Extraordinary General Meeting for holders of the Company’s Class A and Class B ordinary shares is planned for November 10, 2025 at 10:00 AM EST. UTime also furnished the meeting Notice and a Form of Proxy Card as Exhibits 99.1 and 99.2.
UTime Limited plans to hold an Extraordinary General Meeting of shareholders on November 10, 2025 at 10:00 AM EST. The meeting is for holders of the Company’s Class A and Class B ordinary shares. The company furnished the Notice of Extraordinary General Meeting as Exhibit 99.1 and the Form of Proxy Card as Exhibit 99.2 under this Form 6-K.
UTime Limited announced it entered into a Memorandum of Understanding with Hainan Fuxinyi Investment Co., Ltd. to collaborate over the next three years to co-develop a professional digital platform for elderly care services.
A press release with additional details is furnished as Exhibit 99.1 to this report.
UTime Limited priced and closed a best‑efforts public unit offering for approximate gross proceeds of $25 million, before fees and expenses. The Company sold 22,727,275 units at $1.10 per unit, each unit consisting of one Class A ordinary share and a warrant to purchase one Class A ordinary share.
Each warrant is exercisable immediately at $1.10 per share and expires one year from issuance, with customary anti‑dilution adjustments. The warrants include a cashless exercise alternative and a zero exercise price option under which holders may receive up to 14 shares per warrant, capped at an aggregate 318,181,850 shares. The offering was made under UTime’s effective Form F‑3 shelf via an October 16, 2025 prospectus supplement and closed on October 17, 2025.
Univest Securities acted as placement agent and will receive an 8.0% cash fee, a 1.0% non‑accountable expense allowance, and up to $150,000 in reimbursed expenses. Directors, officers and certain 5% holders agreed to 90‑day lock‑ups; the Company also agreed to a 90‑day issuance/registration standstill and a 120‑day prohibition on Variable Rate Transactions. Net proceeds will be used for general working capital and corporate purposes.
UTime Limited (WTO) launched a primary offering of 22,727,275 Units at $1.10 per Unit, each Unit including one Class A Ordinary Share and one one-year Warrant. The company is also registering 318,181,850 Class A Ordinary Shares issuable upon Warrant exercise via a disclosed zero exercise price option that allows holders to receive 14 shares per Warrant. The Warrants are immediately exercisable, have an initial cash exercise price of $1.10, and include 4.99% (or 9.99% at election) beneficial ownership limits.
This best‑efforts, no‑minimum offering is expected to deliver approximately $20.8 million in net proceeds to UTime for working capital and general corporate purposes after placement agent fees and estimated expenses. The Warrants are not listed; the Class A Ordinary Shares trade on Nasdaq as “WTO.” Company agreements include a 90‑day issuance lock‑up (with exemptions), a 120‑day prohibition on variable rate transactions, and 90‑day insider lock‑ups. The company does not expect to receive proceeds from Warrant exercises under the zero exercise price option.
UTime Limited (WTO) reported it believes it has regained compliance with Nasdaq’s $2.5 million stockholders’ equity requirement after completing a $25 million private placement of ordinary shares on August 12, 2025. The company estimates approximately $6.69 million in stockholders’ equity on a pro forma basis and says recent cost cuts from discontinuing unprofitable activities support maintaining compliance over the next 12 months.
Nasdaq previously notified UTime on or about August 15, 2025 that it was below the $2,500,000 equity threshold based on its Form 20-F filed August 11, 2025. Nasdaq will continue to monitor compliance and the company may face delisting if its next periodic report does not evidence compliance.
UTime also announced the immediate discontinuation and divestiture of three subsidiaries: Changsha Utime Business Management Co., Ltd., WTO New York Inc., and UT (HK) International Technology Co. Limited. The divestiture process has begun as UTime refocuses on core businesses.
UTime Limited reports that two Form 6-K filings made on September 9, 2025, and related press releases were submitted by an unauthorized individual and contained false information about wholesale leadership changes. The company confirms that no executive officers or directors resigned and that its board and management remain unchanged.
UTime explains that this individual seized control of its EDGAR filing codes, temporarily blocking official access, and that the company worked with the SEC to regain control on October 9, 2025. The refurnished September 11, 2025 press release, attached as Exhibit 99.1, reiterates the continuity of the existing leadership team.
UTime Limited reports significant leadership and board changes. Effective September 8, 2025, the Board removed Mr. Yanzhi Wang as an independent director, chairman of the Audit Committee, and member of the Compensation and Nominating & Corporate Governance Committees.
To fill the resulting vacancies, the Board appointed Ms. Xuan Ouyang as an independent director, chairman of the Audit Committee, and member of the Compensation and Nominating Committees, effective the same date. The Board also approved Mr. Tianlong Wang as Chief Executive Officer and chairman, effective September 8, 2025.
In addition, the company appointed Mr. Shirong Tong and Mr. Zhongping Liu as independent directors with various committee roles, and Ms. Xiaoxia Wu as a director of the Board, all effective September 8, 2025. These changes substantially reshape the company’s board and senior leadership structure.
UTime Limited reported sweeping leadership changes in early September 2025. On September 4, four board members, including Chief Executive Officer and Chairman Hengcong Qiu, resigned effective immediately. Each departing director and the CEO stated that their resignations were not the result of any disagreement with the company’s operations, policies, or practices.
On September 8, the board appointed Tianlong Wang as the new Chief Executive Officer and chairman, and named Shirong Tong, Zhongping Liu, and Xiaoxia Wu as new directors. The filing notes that there are no special arrangements underlying these appointments and no family relationships between the new appointees and existing directors or executive officers. The new leaders bring experience in management, academia, human resources, and investment management.